MRI-changes in Morphometry and Cerebro Spinale Fluid (CSF) Flow in Spinal Cord Disorders
Launched by UNIVERSITY OF ZURICH · Jun 19, 2014
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how changes in the spinal cord and the flow of fluid around it can affect people with spinal injuries. The goal is to learn more about how these changes occur and how they relate to the symptoms patients experience. By using MRI scans, researchers hope to understand the structure of the spinal cord and the movement of cerebrospinal fluid, which cushions and protects the spinal cord. This information could help doctors diagnose and treat spinal injuries more effectively, potentially preventing further disability.
To be eligible for this study, participants should be between 18 and 80 years old and have a cervical spinal injury. They must also be able to give informed consent and not have any other neurological or psychiatric disorders, seizures, or be pregnant. If you join the trial, you may undergo certain tests, including an MRI and possibly having your spinal fluid pressure measured during a surgery. This will help researchers see how these factors influence each other and the overall health of the spinal cord.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cervical injury
- • Informed consent
- • Age 18-80
- • CSM
- Exclusion Criteria:
- • No other neurologic disorder and psychiatric disorder
- • Seizure
- • MRI incompatibility
- • Pregnancy
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials